Forbes Medi-Tech Inc. About
Forbes Medi- Tech Inc Forbes Medi-Tech Inc. is a biopharmaceutical
company dedicated to the research, development and commercialization of innovative
prescription pharmaceutical and nutraceutical products derived from by-products
of the forestry industry and other natural sources for the prevention and treatment
of cardiovascular and related diseases. The Company's scientific platform is based
on core sterol technology. Forbes has developed cholesterol-lowering
agents for use in pharmaceutical compounds, functional foods and dietary supplements.
FM-VP4 FM-VP4, a novel analogue
of phytostanols, has demonstrated dramatic cholesterol-lowering and anti-atherosclerotic
properties in pre-clinical trials. FM-VP4 is currently being evaluated in a Phase
II clinical trial at the Academic Medical Center, University of Amsterdam, one
of the world's leading centers for the research and management of dyslipidemia.
The FM-VPx Library of Compounds represents a group of synthetic entities
with therapeutic potential targeting the cardiovascular market. These compounds
may have additional benefits including: triglyceride-lowering, increasing HDL
(good cholesterol),
anti-obesity, anti-diabetic,
and anti-inflammatory. More
on Forbes Medi-Tech Key
Statistics for Forbes Medi-Tech
Basic
Chart for Forbes Medi-Tech